Followers | 800 |
Posts | 118388 |
Boards Moderated | 0 |
Alias Born | 11/20/2004 |
Monday, November 02, 2020 4:40:27 PM
RESEARCH TRIANGLE PARK, N.C, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, today announced it has rescheduled its special meeting of stockholders, which was originally scheduled for October 21, 2020, to be held at 4:30 p.m., Eastern Time, on November 13, 2020. The special meeting will be a virtual meeting conducted solely online via live webcast and can be attended by visiting www.meetingcenter.io/287587626.
As previously announced, on October 16, 2020, the Company received an unsolicited offer to enter into a License Agreement for the Company’s LIQ861 product candidate (the “Alternative Proposal”). The Alternative Proposal was conditioned upon the Company terminating the Agreement and Plan of Merger, dated as of June 29, 2020, by and among the Company, RareGen, LLC, Liquidia Corporation, Gemini Merger Sub I, Inc., Gemini Merger Sub II, LLC, and PBM RG Holdings, LLC (the “Merger Agreement”). On November 1, 2020, the Company’s board of directors (the “Board of Directors”) has determined that the Alternative Proposal does not constitute a Superior Proposal and the Company subsequently informed the counterparty that it is terminating discussions with respect to such Alternative Proposal.
Accordingly, the Board of Directors has unanimously reaffirmed its recommendations that the Company’s stockholders vote “FOR” each proposal being submitted to a vote of the Company’s stockholders at the Special Meeting.
Recent LQDA News
- Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 01:00:10 PM
- Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder • GlobeNewswire Inc. • 04/01/2024 10:00:44 AM
- Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/13/2024 10:00:00 AM
- Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 11:30:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:07:54 AM
- Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress • GlobeNewswire Inc. • 01/30/2024 11:30:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 12:01:42 PM
- Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder • GlobeNewswire Inc. • 01/25/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 12:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 12:01:41 PM
- Liquidia Corporation Announces Updates to Operations Leadership • GlobeNewswire Inc. • 01/19/2024 11:30:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:04:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:03:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:02:54 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/16/2024 12:42:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:15:50 PM
- Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims • GlobeNewswire Inc. • 01/08/2024 01:22:54 PM
- Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD • GlobeNewswire Inc. • 01/05/2024 11:45:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 02:37:39 AM
- Liquidia Corporation Announces $100 Million in New Financings • GlobeNewswire Inc. • 01/04/2024 02:10:24 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/04/2024 05:15:19 AM
- Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 11:45:31 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/28/2023 09:30:50 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 09:08:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 10:16:18 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM